Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Liliana Chemello"'
Autor:
Liliana Chemello, Massimo A. Padalino, Loira Leoni, Gino Gerosa, Giovanni Di Salvo, Giuseppe Toscano, Matteo Ponzoni, Vladimiro L. Vida, Biagio Castaldi
Publikováno v:
European Journal of Cardio-Thoracic Surgery. 61:338-345
OBJECTIVES Fontan patients are known to suffer from clinical attrition over the years, which has been characterized as Fontan failure. We sought to evaluate the clinical outcomes of such Fontan patients undergoing surgical management in a 25-year, si
Publikováno v:
Minerva Gastroenterology. 67
Introduction Neurologic and neuropsychiatric manifestations sometimes provide the first evidence of an unknown HCV infection. These conditions develop with a variable ranging of morbidity, including: "brain fog," fatigue, subtle cognitive and attenti
Autor:
Vladimiro Vida, Giovanni Di Salvo, Massimo A. Padalino, Roberta Biffanti, Luisa Cavalletto, Biagio Castaldi, Luisa Benvegnù, Chiara Zanon, Liliana Chemello, Daniela Mancuso
Publikováno v:
International Journal of Cardiology Congenital Heart Disease, Vol 5, Iss, Pp 100251-(2021)
Autor:
Chiara Zanon, Daniela Mancuso, Massimo A. Padalino, Roberta Biffanti, Liliana Chemello, Luisa Cavalletto, Luisa Benvegnù
Publikováno v:
Journal of Cardiovascular Development and Disease
Volume 8
Issue 10
Journal of Cardiovascular Development and Disease, Vol 8, Iss 117, p 117 (2021)
Volume 8
Issue 10
Journal of Cardiovascular Development and Disease, Vol 8, Iss 117, p 117 (2021)
Fontan-associated liver disease (FALD) is an arising clinical entity that can occur long after a successful Fontan operation for correction of single ventricle (SV) congenital heart disease (CHD). Occurrence of FALD is characterized by liver cirrhosi
Publikováno v:
Journal of Cardiovascular Development and Disease, Vol 8, Iss 30, p 30 (2021)
Journal of Cardiovascular Development and Disease
Journal of Cardiovascular Development and Disease
The Fontan operation is the current surgical procedure to treat single-ventricle congenital heart disease, by splitting the systemic and pulmonary circulations and thus permitting lifespan to adulthood for the majority of newborns. However, emerging
Autor:
Alessio Aghemo, Roberto Filomia, Elisa Biliotti, Barbara Coco, M. De Siena, D.A. Amoruso, D. Ieluzzi, S. Bruno, Lorenzo Badia, Marco Massari, Pierluigi Blanc, M. Puoti, Liliana Chemello, Elisabetta Degasperi, Giustino Parruti, M.G. Quaranta, Loreta A. Kondili, Maria Cristina Vinci, V. Panetta, Francesco Russo, Valentina Cossiga, Monica Monti, Andrea Iannone, I. Beretta
Publikováno v:
Digestive and Liver Disease. 52:e7
Autor:
Maria Grazia Rumi, Teresa Santantonio, Vincenza Calvaruso, D.C. Amoruso, Giovanni Raimondo, Salvatore Petta, Maria Cristina Pasetto, Romina Corsini, Alfredo Di Leo, Anna Linda Zignego, Barbara Coco, Francesco Paolo Russo, Giovanni Battista Gaeta, Maurizia Rossana Brunetto, Giuseppina Brancaccio, Veronica Bernabucci, Alberto Zanetto, Filomena Morisco, Mario Masarone, Pietro Andreone, Pierluigi Blanc, D. Ieluzzi, Salvatore Madonia, Adele Giammario, Marzia Margotti, Edoardo G. Giannini, M. Cannizzaro, Emanuela Zappulo, Gloria Taliani, Monica Monti, Roberto Filomia, Marco Massari, Guglielmo Borgia, Andrea Iannone, Massimo Siciliano, Erica Villa, Marcello Persico, Stefano Vella, Stefano Rosato, Maria Giovanna Quaranta, L. E. Weimer, Carmine Coppola, Liliana Chemello, Loreta A. Kondili, Barbara Del Pin, Loredana Falzano, Luchino Chessa, L. Donnarumma, Luisa Cavalletto, Elisa Biliotti, Antonio Gasbarrini
Publikováno v:
PLoS ONE, Vol 12, Iss 10, p e0185728 (2017)
PLoS ONE
PLoS ONE
Background: Few data are available on the virological and clinical outcomes of advanced liver disease patients retreated after first-line DAA failure. Aim: To evaluate DAA failure incidence and the retreatment clinical impact in patients treated in t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::319d91dddf3ce87a8ea1f347c24a5d39
http://hdl.handle.net/11577/3252831
http://hdl.handle.net/11577/3252831
Autor:
Enzo Raise, Giulio Diodati, Elisabetta Bernardinello, Angelo Gatta, Liliana Chemello, Luisa Cavalletto
Publikováno v:
Farmeconomia: Health Economics and Therapeutic Pathways, Vol 9, Iss 4, Pp 173-181 (2008)
The current standard of care for the treatment of chronic hepatitis C virus (HCV) infection is combination therapy with Peg-interferon (IFN) alpha-2a or alpha-2b type plus ribavirin (RBV). This antiviral schedule can in fact avoid the three fold mort
Autor:
Bettina E. Hansen, Ming Y. Lai, Ola Weiland, Liliana Chemello, Anna Hollander, Johannes T. Brouwer, A. Bellobuono, Peter Michielsen, Ding-Shinn Chen, Solko W. Schalm, Michele Milella, Giuseppe Pastore
Publikováno v:
Gastroenterology, 117, 408-413. W.B. Saunders
Background & Aims: The aim of this study was to compare interferon (IFN)-ribavirin combination therapy with IFN monotherapy in chronic hepatitis C with particular focus on its efficacy in cirrhosis. Methods: A multivariate analysis of individual pati
Autor:
Attilio Cecchetto, Giovanna Fattovich, Federico Tremolada, Liliana Chemello, Franco Noventa, Alfredo Alberti, Luisa Benvegnù
Publikováno v:
Cancer. 74:2442-2448
Background. Patients with cirrhosis have a high risk of hepatocellular carcinoma (HCC) but it is unclear how the etiology of liver disease influences tumor development. The authors evaluated hepatitis B and C virus (HBV, HCV) infection in cirrhosis i